Evidence suggests that the hyperammonemia (HA)-induced neuroinflammation and alterations in the serotonin (5-HT) system may contribute to cognitive decline and anxiety disorder during hepatic encephalopathy (HE). Probiotics that maintain immune system homeostasis and regulate the 5-HT system may be potential treatment for HA-mediated neurological disorders in HE.
Patients with liver cirrhosis very frequently develop hepatic encephalopathy (HE), a neuropsychiatric syndrome primarily including cognitive impairment and emotional disorder [1, 2] . Hyperammonemia (HA) is suggested to be a main factor responsible for these neurological disorders occurring in HE [35] , and its mechanisms of action are currently under investigation in animal and clinical studies. Data from these studies suggest that HA induced cognitive impairment may be mediated by neuroinflammation [6, 7] . Furthermore, these studies support the idea that anxiety disorder, one of the emotional disorders commonly observed in patients with HE [8] , is associated with alterations in serotonin (5-HT) metabolic activity [911] resulting from HA [12] . Moreover, the kynurenine pathway (KP), which converts tryptophan (TRP) to L-kynurenine (KYN), may also be involved in modulating HA-induced anxiety disorder because TRP is the precursor for 5-HT synthesis [13] [14] [15] .
Animal models of HA are crucial for elucidating potential pathophysiological mechanisms and thus, developing possible therapies for HE. Current animal models of chronic HA are generally limited to rats and mice, and have been designed to predominantly study the effects of HA per se on brain function [16] . The injection of ammonium acetate intraperitoneally (i.p.) has been shown to be successful in demonstrating HA-induced alterations in the brain [17] [18] [19] . These experiments are inexpensive and simple to perform.
Classic therapeutic approaches for HE involve the reduction of HA levels via antibiotic treatment and administration of nonabsorbable sugars, such as lactulose [20, 21] . These treatments, however, are not optimal therapies because of their side effects, toxicities, and poor compliance from patients [22] . Probiotics, such as the Lactobacillus species, are living microorganisms that contribute to the balance of intestinal microbiota, thereby improving the health of the host. Probiotics may have the potential to treat the neurological disorders associated with HE, because of their ability to suppress the pro-inflammatory response [23, 24] and regulate the activity of the 5-HT system [25] . Indeed, data from animal and clinical studies have revealed that probiotics can improve cognitive function [26] and decrease anxiety and depression symptoms [25, [27] [28] [29] . However, the mechanism by which probiotic bacteria residing in the gut enable their protective effects to the central nervous system remains unclear.
Therefore, the overall aim of this study was to assess the efficacy of the probiotic Lactobacillus helveticus (L. helveticus) strain NS8 in preventing cognitive impairment and anxiety-like behavior in HA rats. L. helveticus has been shown to inhibit pro-inflammatory responses and improve murine brain function and behavior [30, 31] .
Materials and methods

Animals
Specific-pathogen-free male Sprague-Dawley rats (180-200 g) (Vital River Animal Centre, China) were used in the study. Rats were housed individually in wire-mesh cages in an animal room at a controlled temperature (20±2°C), with a relative humidity of 50%-55%, and exposed to a 12:12 h light/dark cycle. Animals had ad libitum access to standard laboratory rodent chow and fresh sterile water. Three groups of animals (six rats per group) were used in the study: (i) sterile saline-injected (i.p.) rats exposed to fresh sterile water (control group), (ii) HA rats exposed to fresh sterile water (HA group), and (iii) HA rats exposed to fresh sterile water containing L. helveticus NS8 (HA+NS8 group). The experimental protocol was approved by the Animal Experiment Ethics Committee of the Institute of Psychology, Chinese Academy of Sciences.
HA rat model
HA was induced by 2.5 mmol kg 1 body weight ammonium acetate (Sigma-Aldrich, USA) (i.p.) dissolved in the sterile saline, once per day, three times per week for four consecutive weeks [19, 32] .
L. helveticus NS8 strain and culture conditions
The L. helveticus strain NS8 (GenBank accession No. JQ013296.1) was isolated by our laboratory from natural fermented dairy products collected from grassland in Inner Mongolia, China. L. helveticus strain NS8 was stored in DeMan-Rogosa-Sharpe (MRS) broth (Biokar Diagnostics, France) at -80°C, and subcultured twice in MRS broth for 18 h at 37°C prior to its use in experiment. Overnight cultures were centrifuged twice at 1500×g for 5 min, cells collected and resuspended in fresh sterile water (10 9 CFU mL 1 ) [33] . NS8-containing drinking water (probiotic treatment) was given to HA rats over two weeks. A high bacterial viability was maintained by supplying fresh L. helveticus NS8-containing drinking daily. The daily dosages of probiotics ingested by the rats were measured by the daily amount of water consumed.
Experimental design
Two weeks acclimatization of all rats (week 1-2), ammonium acetate or saline was administered for four weeks (week 3-6) to induce chronic HA or serve as control, respectively ( Figure 1) . HA rats were then given L. helveticus NS8-containing drinking water or sterile water (week 7-8). Anxiety-like behavior and cognitive function were tested (at week 9) using the elevated plus maze (EPM) and Morris water maze (MWM), respectively. Animals continued to receive either ammonium acetate or sterile saline during probiotic administration and behavioral tests (week 7-9) to prevent spontaneous recovery from HA. During the behavioral tests, animals continued to drink either sterile water containing L. helveticus NS8 or sterile water.
Blood samples (20 μL) were collected (via a small tail incision) for the measurement of ammonia concentrations at the end of HA or saline treatment (week 6). The daily amount of water consumed was measured at the end of the two-week probiotic or water treatment (week 8). Rats were sacrificed by decapitation after the final MWM test. The trunk blood was collected and the brain was removed immediately for further dissection.
The EPM test
The EPM test is widely used to measure anxiety-like behavior in response to a novel environment and height. The time spent in and number of entries into the open arms were taken as indices of anxiety. These parameters were expressed as a percentage of the total time spent and the total entries into any arm during the 5 min test session [34] .
The EPM consisted of a center area (10 cm×10 cm) with two opposite closed arms (a 10 cm wide, 50 cm long, and 30 cm high wall at their sides and far end) and two opposite open arms (10 cm wide, 50 cm long) arranged as a plus [34] . The device was made of opaque black polypropylene and elevated 50 cm above the floor.
Rats were placed individually in the center of the maze facing an open arm, and were allowed 5 min of free exploration. Movements of the animals during the 5-min test period were tracked by a video camera positioned above the center of the maze and were analyzed using the ANY-Maze (Stoelting, USA) video tracking system.
The MWM task
The Morris Water Maze consisted of a dark circular pool (140 cm in diameter and 55 cm high) filled (25 cm deep) with water (20±1°C) [35] . The pool was divided into four zones (arbitrarily designated into north-east, south-east, south-west, and north-west orthogonal quadrants) by the ANY-Maze software (Stoelting, USA). Extra maze cues surrounded the walls of the room where the water maze was situated.
The MWM task lasted for 6 d. During the first four days, rats were trained over four trials per day. The platform (11 cm in diameter) was submerged 1.5 cm from the water surface (and rendered invisible) in the center of the south-west quadrant. In each trial, rats were placed in front of the wall but at a different starting position (north, east, south and west). Rats were free to swim and find the hidden platform within 120 s. The escape latency to find the hidden platform is taken as an index of learning ability [35] . On day 5, a spatial probe test was used to assess retention of spatial memory by the swim time in the target zone. For this test, the hidden platform was removed and rats were free to swim for 120 s from the north-east orthogonal quadrant of the pool, a starting position furthest away from the hidden platform. On day 6, a visible platform (not submerged in water) covered by a piece of aluminum foil was placed in another position (the south-east quadrant) to test swimming ability and motivation of the rats.
Measurement of blood ammonia
Blood ammonia levels were measured using a Blood Ammonia Checker AA-4120 (ARKRAY, Inc., Japan). The measuring range was 10-400 μg dL 1 .
Measurement of neuroinflammatory markers
Measurements were carried out in the cerebellum, hippocampus and prefrontal cortex, which are brain regions known to be crucially involved in cognitive function and emotional state [36, 37] . These brain regions were removed according to Desbonnet et al. [25] . Briefly, brain regions were quickly isolated on ice, weighed, then snapped frozen by liquid nitrogen and stored at -80°C until analysis. Brain tissues were homogenized in phosphate buffered saline (0.1 mol L 1 ) containing a protease inhibitor cocktail (AMRES-COLLC, USA). The homogenate was centrifuged (3000×g, 10 min, at 4°C). Prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS) and interleukin-1 beta (IL-1β) were measured from the supernatant by enzyme-linked immunosorbent assay (ELISA) kits (RapidBio Lab, USA), according to the manufacturer's protocol.
Measurement of the metabolic activity of brain 5-HT
5-HT and its metabolite 5-hyroxyindole acetic acid (5-HIAA) were measured in the supernatant of the prefrontal cortex, hippocampus and cerebellum using ELISA kits (RapidBio Lab), according to the manufacturer's protocol.
Analysis of the kynurenine pathway in plasma
Trunk blood was collected in pre-chilled ethylenediaminetetraacetic acid-coated blood collection tubes, and plasma was separated by centrifugation (1500×g, 10 min, at 4°C) and immediately stored at -80°C until analysis. Plasma levels of tryptophan (TRP), and its metabolites, L-kynurenine (KYN) and kynurenic acid (KA), were measured by ELISA kits (RapidBio Lab), according to the manufacturer's instructions.
Statistical analysis
All data are presented as the mean±SEM. The two-way analysis of variance (ANOVA) was used to identify training days 1-4 of MWM task, treatment effects, and interactions between these factors, and the other data were analyzed by one-way ANOVA. (Figure 2A and B) . Probiotic treatment of HA rats significantly (P<0.05) increased the percentage of number of entries into the open arms (39.7%±2.1%) ( Figure 2B ), but had no effect on the time spent in the open arms, compared with HA rats.
Probiotic treatment improved learning and memory abilities of the MWM task in HA rats
The escape latency to find the hidden platform was significant different (P<0.01) among the three groups over training days 1-4 (Figure 3) . Although the three groups were not significantly different on day 1, the escape latency to find the hidden platform was significantly increased in HA rats compared with the control on day 2, day 3 and day 4 (day 2: 110.1±5. 11.3±1.5 s, day 4: 5.7±0.4 s) compared to HA rats, suggesting that probiotic treatment enhances learning ability (Figure 3) . The interaction between the factors training days and treatment effects was significant (P<0.01).
The percentage of swim time in the target zone is taken as an index of memory retention. The percentage of swim time in the target zone was significantly (P<0.01) reduced in HA rats (22.7%±0.7%) compared with control rats (32.4%±0.8%) (Table 1) . However, probiotic treatment sig- nificantly (P<0.01) increased the percentage of swim time to 35.5%±1.2%, which is significantly greater than in HA rats ( Table 1 ). The escape latency to find the visible platform and swim speed were not significantly different between the three groups (Table 1) ; thus, swimming ability was unaffected. Figure 4C ). Figure 5B ). Probiotic treatment of HA rats did not affect 5-HIAA levels in any of the tested brain regions ( Figure 5B ), but significantly (P<0.01) reduced the concentration of 5-HT in the cerebellum and hippocampus, compared with HA rats ( Figure 5A ).
Probiotic
Probiotic treatment of HA rats affected the plasma kynurenine pathway
HA treatment significantly increased plasma levels of TRP (30280±1089 pmol mL 1 vs. 23590±1260 pmol mL 1 , P<0.01), compared with the control (Figure 6A ). Furthermore, HA treatment significantly decreased KYN/TRP (0.0121±0.0006l vs. 0.0253±0.001, P<0.01), and increased KA/KYN ratio (1.4±0.09 vs. 0.8±0.1, P<0.01), compared with the control (Figure 6B ). Probiotic treatment of HA rats markedly increased (P<0.01) and decreased (P<0.05) the ratio of KYN/TRP (0.022±0.001) and KA/KYN (0.9±0.06), respectively, compared with HA rats ( Figure 6B ).
Discussion
In the present study, chronic HA induces cognitive decline and anxiety-like behavior in rats, supporting the idea that HA-mediate HE leads to neurological dysfunctions. Furthermore, probiotic treatment of HA rats with the L. helveticus NS8 improves cognitive decline and anxiety-like behavior, suggesting that this probiotic strain may be benefi- cial for the treatment of neurological dysfunctions in HA rats.
Effect of L. helveticus NS8 on cognitive function and neuroinflammation
The mechanism by which HA impairs cognitive function is beginning to be clarified in animal studies. Portacaval shunts (PCS) rats have been found to develop learning impairment of the Y-maze task. These rats exhibit HA and neuroinflammation [36] . Treatment of PCS rats with the anti-inflammatory, ibuprofen, reduces neuroinflammation but not HA, and also restores learning ability [38] . Furthermore, data from a rat model of chronic HA have suggested that neuroinflammation mediates the deleterious effects of HA on cognitive function [1]. These results suggest that HA may induce neuroinflammation-mediated cognitive impairment. In support of this pathogenic role, our study shows that HA induces neuroinflammation in the cerebellum, hippocampus and prefrontal cortex, and impairs learning ability and spatial memory in rats. Therefore, probiotic treatment may be beneficial for HA-mediated cognitive decline in rats given because cognitive decline is improved and neuroinflammation is attenuated with this treatment.
A main mechanism of HA-induced neuroinflammation is the release of pro-inflammatory molecules from activated microglia [1] . Moreover, the transcription factor, nuclear factor kappa B (NF-κB), plays a critical role in microglial activation [39] . Therefore, in the present study, probiotic treatment may have attenuated neuroinflammation by suppressing the activation of NF-κB. In support of this hypothesis, related studies have reported that suppression of inflammation can occur in response to probiotic Lactobacillus-mediated inhibition of NF-κB activation [40, 41] .
Effect of L. helveticus NS8 on anxiety-like behavior and 5-HT metabolism
A dysfunctional of 5-HT system has long been implicated in the pathogenesis of anxiety disorders [42] . Thus, the anxiety-like behavior observed in HA rats of the present study may have resulted from changes in the central 5-HT system. In support of this theory, our results showed that HA rats had enhanced 5-HT metabolism in the cerebellum, hippocampus and prefrontal cortex, as reflected by increased levels of 5-HIAA but unchanged levels of 5-HT. A previous study found similar results in PCS-induced HA rats that displayed elevated 5-HIAA but unaltered 5-HT levels, and when challenged with ammonium acetate, 5-HT release was transiently elevated [9, 12] .
Indeed, results from related studies have suggested an association between the hyperactivity of the 5-HT system and an increased susceptibility to develop an anxiety disorder. Iversen [43] proposed that an increase in brain 5-HT concentration elevates anxiety while a decrease in brain 5-HT level reduces anxiety. Moreover, reduced wholetissue level of 5-HT in regional brain was linked to a low-anxiety phenotype in transgenic mice overexpressing 5-HT transporter [44] . Therefore, the results observed in the present study, that L. helveticus NS8 reduces the levels of 5-HT in the cerebellum and hippocampus, and improves anxiety-like behavior in HA rats, may suggest that this probiotic may be beneficial in the treatment of anxiety disorder in HA rats.
Effect of L. helveticus NS8 on kynurenine pathway
5-HT synthesis in the brain is crucially dependent on its precursor TRP. Therefore, enhanced 5-HT metabolism in HA rats of the present study may be attributed to a significant rise in TRP. Peripheral TRP concentration is increased and correlates well with central TRP, 5-HT and 5-HIAA levels in HE patients [10, 45] . L. helveticus NS8-mediated reduction of 5-HT metabolism in HA rats in the current study was possibly due to enhanced TRP degradation because the KYN/TRP ratio was increased, despite the levels of TRP themselves remaining unchanged.
The kynurenine pathway is the major route for TRP metabolism, in which indoleamine 2,3-dioxygenase (IDO) converts TRP to KYN [46] . In the current study, the rise in the KYN/TRP ratio in HA rats treated with probiotics may indicate that probiotics enhance IDO activity. IDO is expressed in various cell types, and is widely involved in immunomodulatory activity [47] , such as anti-inflammatory effect and protective role in a mouse model of colitis [48] . Therefore, in the present study, improved anxiety-like behavior in probiotic treatment of HA rats may be a result of an immunomodulatory effect of this treatment through enhanced IDO activity, the promotion of TRP depletion, and reduction of 5-HT metabolism. Similarly in another study, attenuation of the allergic airway response was found to be due to an increase in systemic IDO activity induced by administration of live Lactobacillus reuteri [49] . However, our results are contradicted by other studies that have shown suppression of IDO production in response to treatment of the probiotic Bifidobacterium species or Lactobacillus johnsonii in a rat model of depression [25, 50] . In the mouse model of allergic airway inflammation, it is important to note that the IDO activity was enhanced only following the administration of Lactobacillus reuteri but not Lactobacillus salivarius [49] . These data suggest that different probiotic species or strains may have different effects on IDO activity. Furthermore, KA produced from KYN has been shown to enhance anxiety because it can decrease the extracellular level of glutamate [51, 52] . Results from our study show an increase in the KA/KYN ratio in HA rats but a decrease of that following probiotic treatment, thus providing further evidence for the potential anxiolytic properties of the probiotic L. helveticus strain NS8.
In conclusion, the data from our study suggest that ad-ministration of probiotic L. helveticus strain NS8 is a potential therapeutic approach for HA-mediated cognitive decline and anxiety-like behavior. The effect of probiotic treatment on improving behaviors may be attributed to its immunomodulatory properties of attenuating neuroinflammation and reducing 5-HT metabolism. We therefore provide strong evidence supporting the possible use of probiotic treatment for neurological disorders in addition to its use in the gastrointestinal tract. A better understanding of the behavioral effect of probiotics would require further investigations of their immunomodulatory activity.
